Pura Vida Investments LLC bought a new stake in Halyard Health Inc (NYSE:HYH) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 75,000 shares of the medical instruments supplier’s stock, valued at approximately $3,377,000. Halyard Health comprises about 1.5% of Pura Vida Investments LLC’s holdings, making the stock its 28th biggest holding. Pura Vida Investments LLC owned approximately 0.16% of Halyard Health as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in the stock. Amalgamated Bank raised its position in Halyard Health by 1.2% in the 2nd quarter. Amalgamated Bank now owns 6,655 shares of the medical instruments supplier’s stock valued at $261,000 after buying an additional 82 shares during the last quarter. Texas Permanent School Fund raised its position in Halyard Health by 0.8% in the 2nd quarter. Texas Permanent School Fund now owns 34,074 shares of the medical instruments supplier’s stock valued at $1,338,000 after buying an additional 284 shares during the last quarter. Arizona State Retirement System raised its position in Halyard Health by 1.5% in the 2nd quarter. Arizona State Retirement System now owns 19,700 shares of the medical instruments supplier’s stock valued at $774,000 after buying an additional 300 shares during the last quarter. Capstone Asset Management Co. raised its position in Halyard Health by 6.2% in the 2nd quarter. Capstone Asset Management Co. now owns 5,663 shares of the medical instruments supplier’s stock valued at $222,000 after buying an additional 330 shares during the last quarter. Finally, ETRADE Capital Management LLC raised its position in Halyard Health by 4.2% in the 2nd quarter. ETRADE Capital Management LLC now owns 9,671 shares of the medical instruments supplier’s stock valued at $380,000 after buying an additional 390 shares during the last quarter. 90.31% of the stock is currently owned by institutional investors and hedge funds.

Halyard Health Inc (HYH) opened at $47.53 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19. The firm has a market capitalization of $2,202.72, a P/E ratio of 22.50, a price-to-earnings-growth ratio of 2.54 and a beta of 1.77. Halyard Health Inc has a one year low of $35.24 and a one year high of $50.99.

Halyard Health (NYSE:HYH) last posted its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.13. The firm had revenue of $401.40 million during the quarter, compared to the consensus estimate of $394.54 million. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The business’s revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $0.48 earnings per share. equities research analysts predict that Halyard Health Inc will post 2.08 EPS for the current year.

HYH has been the topic of a number of recent research reports. BidaskClub raised Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. Stifel Nicolaus reissued a “buy” rating and issued a $45.00 target price on shares of Halyard Health in a research report on Thursday, September 21st. Zacks Investment Research lowered Halyard Health from a “buy” rating to a “sell” rating in a research report on Wednesday, October 4th. KeyCorp reissued a “hold” rating on shares of Halyard Health in a research report on Tuesday, October 17th. Finally, TheStreet lowered Halyard Health from a “b-” rating to a “c+” rating in a research report on Monday, October 30th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Halyard Health has a consensus rating of “Buy” and an average price target of $46.25.

TRADEMARK VIOLATION WARNING: “Pura Vida Investments LLC Takes $3.38 Million Position in Halyard Health Inc (HYH)” was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.watchlistnews.com/pura-vida-investments-llc-takes-3-38-million-position-in-halyard-health-inc-hyh/1763521.html.

Halyard Health Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with Analyst Ratings Network's FREE daily email newsletter.